Brainsway (BWAY) Net Equity Issued and Repurchased (2019 - 2024)
Brainsway (BWAY) posted quarterly Net Equity Issued and Repurchased of $16.4 million for Q4 2024, up 30954.72% on a QoQ basis from -$53000.0 in Q3 2022.
Brainsway (BWAY) Net Equity Issued and Repurchased (2019 - 2024) Analysis & Trends
Brainsway (BWAY) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $16.4 million the latest figure, recorded in Q4 2024.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $16.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $16.3 million (changed N/A YoY) and the FY2024 annual result came in at $16.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $16.4 million in Q4 2024 per BWAY's latest filing, from -$53000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for BWAY reached as high as $42.3 million in Q1 2021 and fell as low as -$53000.0 in Q3 2022.
- A 3-year average of $14.6 million and a median of $8.2 million in 2022 frame the typical range for Net Equity Issued and Repurchased.
- The largest YoY upside for Net Equity Issued and Repurchased was 100.0% in 2022 against a maximum downside of 100.0% in 2022.
- Year by year, Net Equity Issued and Repurchased stood at $42.3 million in 2021, then slumped by 100.13% to -$53000.0 in 2022, then surged by 30954.72% to $16.4 million in 2024.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $16.4 million, -$53000.0, and $1000.0 for Q4 2024, Q3 2022, and Q1 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 16.35 Mn |
| Dec 31, 2024 | 16.35 Mn |
| Sep 30, 2022 | -53,000.00 |
| Sep 30, 2022 | -53,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2021 | 42.26 Mn |
| Mar 31, 2021 | 42.26 Mn |
| Jun 30, 2019 | 26.33 Mn |
| Jun 30, 2019 | 26.33 Mn |